This June, the Consorcio Centro de Investigación Biomédica en Red, M.P. – CIBER, the Advanced Biological Laboratories S.A. – ABL and the Vall d’Hebron Research Institute – VHIR have signed a collaboration agreement to develop an analysis software for the high resolution subtyped results obtained on the research of Hepatitis C virus, and obtained through Next Generation Sequencing methods in the diagnosis field.
This collaboration will create an updated link between the ABL laboratories, who will analyze the results from the deep sequencing by using the software DeepCheck-HCV Next Generation Sequencing. This software will generate a useful report for the clinical practice.
By this means, a new collaboration is created within the frame of software development for the analysis of data generated through Massive Sequencing (NGS), a methodology that has triggered, from the beginning of XXI Century, the movement of personalized medicine. This collaboration will personalize the treatment of the patients infected by Hepatitis C virus by bringing high resolution information.
Example of report of the new software.